Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?

Saved in:
Bibliographic Details
Published in:The Journal of infection 2021-07, Vol.83 (1), p.e11-e13
Main Authors: Hasan, Md. Jahidul, Rabbani, Raihan, Anam, Ahmad Mursel, Huq, Shihan Mahmud Redwanul
Format: Article
Language:English
Subjects:
Letter to the Editor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53
cites cdi_FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53
container_end_page e13
container_issue 1
container_start_page e11
container_title The Journal of infection
container_volume 83
creator Hasan, Md. Jahidul
Rabbani, Raihan
Anam, Ahmad Mursel
Huq, Shihan Mahmud Redwanul
description
doi_str_mv 10.1016/j.jinf.2021.05.011
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8139439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016344532100253X</els_id><sourcerecordid>2532251639</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi1ERYfCC7Dykk3C8SWeGCFQNYV2pEpdFNhajn1MPSTOYCcj8fZkNBVSN12dxX850v8R8o5BzYCpD7t6F1OoOXBWQ1MDYy_IijWCV3wt-UuyWkyikrIR5-R1KTsA0EKrV-RcSOBa8XZFtvfo5t8xzYPtaEy04AEz0s3dz-1VxTTdJ5yHMUX7kV6NWGic6IM9ILXU9TFFZ3sah71105c35CzYvuDbx3tBfnz7-n1zU93eXW83l7eVk4JPVee0Z7b1aysBVNMGJ0BDCFKptQs2gHCylRK6Dq2D4NdKiuC1Ao9cKd-IC_L51LufuwG9wzRl25t9joPNf81oo3mqpPhgfo0H0zKhpdBLwfvHgjz-mbFMZojFYd_bhONcDF8W5M0y3dHKT1aXx1Iyhv9vGJgjA7MzRwbmyMBAYxYGS-jTKYTLCoeI2RQXMTn0MaObjB_jc_F_cCiOKA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532251639</pqid></control><display><type>article</type><title>Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?</title><source>ScienceDirect Journals</source><creator>Hasan, Md. Jahidul ; Rabbani, Raihan ; Anam, Ahmad Mursel ; Huq, Shihan Mahmud Redwanul</creator><creatorcontrib>Hasan, Md. Jahidul ; Rabbani, Raihan ; Anam, Ahmad Mursel ; Huq, Shihan Mahmud Redwanul</creatorcontrib><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2021.05.011</identifier><identifier>PMID: 34029628</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Letter to the Editor</subject><ispartof>The Journal of infection, 2021-07, Vol.83 (1), p.e11-e13</ispartof><rights>2021 The British Infection Association</rights><rights>2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. 2021 The British Infection Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53</citedby><cites>FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids></links><search><creatorcontrib>Hasan, Md. Jahidul</creatorcontrib><creatorcontrib>Rabbani, Raihan</creatorcontrib><creatorcontrib>Anam, Ahmad Mursel</creatorcontrib><creatorcontrib>Huq, Shihan Mahmud Redwanul</creatorcontrib><title>Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?</title><title>The Journal of infection</title><subject>Letter to the Editor</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUhi1ERYfCC7Dykk3C8SWeGCFQNYV2pEpdFNhajn1MPSTOYCcj8fZkNBVSN12dxX850v8R8o5BzYCpD7t6F1OoOXBWQ1MDYy_IijWCV3wt-UuyWkyikrIR5-R1KTsA0EKrV-RcSOBa8XZFtvfo5t8xzYPtaEy04AEz0s3dz-1VxTTdJ5yHMUX7kV6NWGic6IM9ILXU9TFFZ3sah71105c35CzYvuDbx3tBfnz7-n1zU93eXW83l7eVk4JPVee0Z7b1aysBVNMGJ0BDCFKptQs2gHCylRK6Dq2D4NdKiuC1Ao9cKd-IC_L51LufuwG9wzRl25t9joPNf81oo3mqpPhgfo0H0zKhpdBLwfvHgjz-mbFMZojFYd_bhONcDF8W5M0y3dHKT1aXx1Iyhv9vGJgjA7MzRwbmyMBAYxYGS-jTKYTLCoeI2RQXMTn0MaObjB_jc_F_cCiOKA</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Hasan, Md. Jahidul</creator><creator>Rabbani, Raihan</creator><creator>Anam, Ahmad Mursel</creator><creator>Huq, Shihan Mahmud Redwanul</creator><general>Elsevier Ltd</general><general>The British Infection Association. Published by Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210701</creationdate><title>Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?</title><author>Hasan, Md. Jahidul ; Rabbani, Raihan ; Anam, Ahmad Mursel ; Huq, Shihan Mahmud Redwanul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Letter to the Editor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasan, Md. Jahidul</creatorcontrib><creatorcontrib>Rabbani, Raihan</creatorcontrib><creatorcontrib>Anam, Ahmad Mursel</creatorcontrib><creatorcontrib>Huq, Shihan Mahmud Redwanul</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasan, Md. Jahidul</au><au>Rabbani, Raihan</au><au>Anam, Ahmad Mursel</au><au>Huq, Shihan Mahmud Redwanul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?</atitle><jtitle>The Journal of infection</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>83</volume><issue>1</issue><spage>e11</spage><epage>e13</epage><pages>e11-e13</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><pub>Elsevier Ltd</pub><pmid>34029628</pmid><doi>10.1016/j.jinf.2021.05.011</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0163-4453
ispartof The Journal of infection, 2021-07, Vol.83 (1), p.e11-e13
issn 0163-4453
1532-2742
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8139439
source ScienceDirect Journals
subjects Letter to the Editor
title Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A37%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secukinumab%20in%20severe%20COVID-19%20pneumonia:%20Does%20it%20have%20a%20clinical%20impact?&rft.jtitle=The%20Journal%20of%20infection&rft.au=Hasan,%20Md.%20Jahidul&rft.date=2021-07-01&rft.volume=83&rft.issue=1&rft.spage=e11&rft.epage=e13&rft.pages=e11-e13&rft.issn=0163-4453&rft.eissn=1532-2742&rft_id=info:doi/10.1016/j.jinf.2021.05.011&rft_dat=%3Cproquest_pubme%3E2532251639%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-bc9d1a8d7a400658fc3090ff4667cfaf03c48440bbeac0fd7643fd960de266d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532251639&rft_id=info:pmid/34029628&rfr_iscdi=true